Dr. Reddy's Laboratories Ltd.NSE: DRREDDY

Press Release Aug 04 2021

· Issued by Dr. Reddy's Laboratories Ltd.

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-aug-04-2021-5

Watch Dr. Reddy's Laboratories' latest callDr. Reddy's Laboratories (NSE:DRREDDY) Q1 2027 Earnings Call · Replay · Jul 22Read the transcript of Dr. Reddy's Laboratories (NSE:DRREDDY) Q1 2027 Earnings Call

Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated August 04, 2021, titled "Dr. Reddy s Laboratories announces entry into definitive agreement with BioDelivery Sciences International, Inc., to sell its U.S. and Canada territory rights for ELYXYB (celecoxib oral solution) 25 mg/mL".

View Attachment

6ix hasn’t read this filing yet.

Dr. Reddy's Laboratories Ltd. on 6ix

Earlier from Dr. Reddy's Laboratories

Later from Dr. Reddy's Laboratories

All Dr. Reddy's Laboratories news releases